Literature DB >> 32755307

SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.

Rafal Bartoszewski1, Michal Dabrowski2, Bogdan Jakiela3, Sadis Matalon4, Kevin S Harrod4, Marek Sanak3, James F Collawn5.   

Abstract

Cold viruses have generally been considered fairly innocuous until the appearance of the severe acute respiratory coronavirus 2 (SARS-CoV-2) in 2019, which caused the coronavirus disease 2019 (COVID-19) global pandemic. Two previous viruses foreshadowed that a coronavirus could potentially have devastating consequences in 2002 [severe acute respiratory coronavirus (SARS-CoV)] and in 2012 [Middle East respiratory syndrome coronavirus (MERS-CoV)]. The question that arises is why these viruses are so different from the relatively harmless cold viruses. On the basis of an analysis of the current literature and using bioinformatic approaches, we examined the potential human miRNA interactions with the SARS-CoV-2's genome and compared the miRNA target sites in seven coronavirus genomes that include SARS-CoV-2, MERS-CoV, SARS-CoV, and four nonpathogenic coronaviruses. Here, we discuss the possibility that pathogenic human coronaviruses, including SARS-CoV-2, could modulate host miRNA levels by acting as miRNA sponges to facilitate viral replication and/or to avoid immune responses.

Entities:  

Keywords:  SARS-CoV; UPR; coronavirus disease 2019 (COVID-19); coronaviruses; miRNA sponges

Mesh:

Substances:

Year:  2020        PMID: 32755307      PMCID: PMC7473886          DOI: 10.1152/ajplung.00252.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  127 in total

1.  Influenza A virus-generated small RNAs regulate the switch from transcription to replication.

Authors:  Jasmine T Perez; Andrew Varble; Ravi Sachidanandam; Ivan Zlatev; Muthiah Manoharan; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  lncRNA-PVT1 Facilitates Invasion Through Upregulation of MMP9 in Nonsmall Cell Lung Cancer Cell.

Authors:  Wei Chen; Huayun Zhu; Li Yin; Tingting Wang; Jianfeng Wu; Jianhua Xu; Hua Tao; Juying Liu; Xia He
Journal:  DNA Cell Biol       Date:  2017-07-21       Impact factor: 3.311

3.  miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.

Authors:  Azam Ahmadi; Behzad Khansarinejad; Saman Hosseinkhani; Mostafa Ghanei; Seyed Javad Mowla
Journal:  Gene       Date:  2017-03-28       Impact factor: 3.688

4.  IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates.

Authors:  Dan Han; Alana G Lerner; Lieselotte Vande Walle; John-Paul Upton; Weihong Xu; Andrew Hagen; Bradley J Backes; Scott A Oakes; Feroz R Papa
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

5.  Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.

Authors:  Fabian Dominik Mairinger; Saskia Ting; Robert Werner; Robert Fred Henry Walter; Thomas Hager; Claudia Vollbrecht; Daniel Christoph; Karl Worm; Thomas Mairinger; Sien-Yi Sheu-Grabellus; Dirk Theegarten; Kurt Werner Schmid; Jeremias Wohlschlaeger
Journal:  Mod Pathol       Date:  2014-05-30       Impact factor: 7.842

6.  Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity.

Authors:  Yogesh Singh; Vandana Kaul; Alka Mehra; Samit Chatterjee; Sultan Tousif; Ved Prakash Dwivedi; Mrutyunjay Suar; Luc Van Kaer; William R Bishai; Gobardhan Das
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

7.  miRBase: from microRNA sequences to function.

Authors:  Ana Kozomara; Maria Birgaoanu; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

8.  An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.

Authors:  Xuelian Li; Yunrui Shi; Zhihua Yin; Xiaoxia Xue; Baosen Zhou
Journal:  J Transl Med       Date:  2014-06-04       Impact factor: 5.531

Review 9.  Editorial focus: entering into the non-coding RNA era.

Authors:  Rafal Bartoszewski; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2018-09-18       Impact factor: 5.787

10.  Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis.

Authors:  Yanwei Qiao; Xuequn Zhao; Jun Liu; Wenjie Yang
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

View more
  30 in total

Review 1.  MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.

Authors:  Jivan Qasim Ahmed; Sazan Qadir Maulud; Manish Dhawan; Om Prakash Choudhary; Paywast Jamal Jalal; Rezhna Kheder Ali; Gahin Abdulraheem Tayib; Dlshad Abdullah Hasan
Journal:  J Infect Public Health       Date:  2022-06-21       Impact factor: 7.537

2.  Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.

Authors:  Rafeed Rahman Turjya; Md Abdullah-Al-Kamran Khan; Abul Bashar Mir Md Khademul Islam
Journal:  Future Virol       Date:  2020-09       Impact factor: 1.831

3.  In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection.

Authors:  Amirhossein Ahmadi; Sharif Moradi
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19.

Authors:  Vitalii Kryvenko; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-09       Impact factor: 5.464

5.  Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients.

Authors:  Ariana Centa; Aline S Fonseca; Solange G da Silva Ferreira; Marina Luise V Azevedo; Caroline B Vaz de Paula; Seigo Nagashima; Cleber Machado-Souza; Anna Flavia R Dos Santos Miggiolaro; Cristina P Baena; Lucia de Noronha; Luciane R Cavalli
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-02       Impact factor: 5.464

6.  MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features.

Authors:  A N Kucher; Iu A Koroleva; A A Zarubin; M S Nazarenko
Journal:  Mol Biol       Date:  2022-02-12       Impact factor: 1.540

Review 7.  MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?

Authors:  Farshad Abedi; Ramin Rezaee; A Wallace Hayes; Somayyeh Nasiripour; Gholamreza Karimi
Journal:  Cell Cycle       Date:  2020-12-31       Impact factor: 4.534

8.  Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells.

Authors:  Dragan Milenkovic; Tatjana Ruskovska; Ana Rodriguez-Mateos; Christian Heiss
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 9.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

Review 10.  The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.

Authors:  Jiulue Hu; Jelena Stojanović; Saman Yasamineh; Pooneh Yasamineh; Sathish Kumar Karuppannan; Mohammed Junaid Hussain Dowlath; Hamed Serati-Nouri
Journal:  Arch Virol       Date:  2021-07-19       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.